Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Should every metastatic prostate cancer patient get germline testing?

No

Date

08 Oct 2016

Session

Should every metastatic prostate cancer patient get germline testing?

Presenters

Bertrand Tombal

Authors

B.F. Tombal

Author affiliations

Cliniques Universitaires St. Luc, 1200 - Brussels/BE

More

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

08 Oct 2016

Introduction and first vote

Presenter: Rob Bristow

Session: Should every metastatic prostate cancer patient get germline testing?

Resources:

Slides

Webcast

08 Oct 2016

Yes

Presenter: Elena Castro Marcos

Session: Should every metastatic prostate cancer patient get germline testing?

Resources:

Slides

Webcast

08 Oct 2016

Second vote and conclusions

Presenter: Rob Bristow

Session: Should every metastatic prostate cancer patient get germline testing?

Resources:

Slides

Webcast